NAVICA Mobile App and BinaxNOW COVID-19 Ag Card
The revolutionary NAVICA™ app helps people navigate daily life in a new normal. NAVICA displays results from the 15-minute BinaxNOW™ COVID-19 Ag Card, a rapid antigen test, to help individuals make informed decisions.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The revolutionary NAVICA™ app helps people navigate daily life in a new normal. NAVICA displays results from the 15-minute BinaxNOW™ COVID-19 Ag Card, a rapid antigen test, to help individuals make informed decisions.
This first-of-its-kind app, available at no-charge, allows people who test negative to get an encrypted temporary digital NAVICA Pass, similar to an airline boarding pass. NAVICA-enabled organizations will be able to verify an individual’s negative COVID-19 test results by scanning the individual’s digital NAVICA Pass to facilitate entry into facilities, along with hand-washing, social distancing, enhanced cleaning, and mask-wearing.
The BinaxNOW™ COVID-19 Ag Card test has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).*
Only available in the US.
THE NAVICA-BINAXNOW TESTING PROCESS IS SIMPLE:
Scan the participant’s NAVICA ID on their mobile device and verify photo ID match.
Scan the unique QR code on the BinaxNOW COVID-19 Ag Card test to create a secure link between the participant and the test card.
Perform the BinaxNOW COVID-19 Ag Card test, following the package insert instructions.
Rescan the QR code on the test card to confirm the link and chain of custody between the BinaxNOW COVID-19 Ag Card test and the participant.
Visually interpret the test result on the card and submit the positive or negative result accordingly via the NAVICA app.
BINAXNOW COVID-19 Ag CARD
A BREAKTHROUGH ANTIGEN TEST
- Simple test procedure using a direct nasal swab
- Direct nasal swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset.**
- Onboard extraction allows the swab to be directly inserted into the test card
- Cost-effective, high performing test designed for decentralized testing
- Room temperature storage
- Visually read results in 15 minutes - no instrument required
- Emergency Use Authorization (EUA) supports testing in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
